Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 21497686)

1.

Combination treatment to CONQUER obesity?

Shah K, Villareal DT.

Lancet. 2011 Apr 16;377(9774):1295-7. doi: 10.1016/S0140-6736(11)60518-7. No abstract available.

PMID:
21497686
2.

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Bays H.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16. Review.

PMID:
20707765
3.

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.

Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N.

J Hypertens. 2014 Jun;32(6):1178-88. doi: 10.1097/HJH.0000000000000145. Review.

4.

New obesity agents: lorcaserin and phentermine/topiramate.

Fleming JW, McClendon KS, Riche DM.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Review.

PMID:
23800750
5.

Fixed-dose combination of phentermine-topiramate for the treatment of obesity.

Halpern B, Faria AM, Halpern A.

Expert Rev Clin Pharmacol. 2013 May;6(3):235-41. doi: 10.1586/ecp.13.13. Review.

PMID:
23656337
6.

Phentermine/topiramate for the treatment of obesity.

Smith SM, Meyer M, Trinkley KE.

Ann Pharmacother. 2013 Mar;47(3):340-9. Review.

PMID:
23482732
7.

Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.

Bays HE, Gadde KM.

Drugs Today (Barc). 2011 Dec;47(12):903-14. doi: 10.1358/dot.2011.47.12.1718738. Review. Erratum in: Drugs Today (Barc). 2012 Jan;48(1):95.

PMID:
22348915
8.

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN.

Hormones (Athens). 2013 Oct-Dec;12(4):507-16. Review.

9.

Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management.

Garvey WT.

Expert Opin Drug Saf. 2013 Sep;12(5):741-56. doi: 10.1517/14740338.2013.806481. Epub 2013 Jun 6. Review.

10.

Clinical inquiries: is immediate-release topiramate an effective treatment for adult obesity?

Harshman H, Kovach F.

J Fam Pract. 2014 Dec;63(12):745-6. Review. No abstract available.

PMID:
25486315
11.

Phentermine and topiramate extended-release for the obesity: new kids on the block.

Katsi V, Marketou M, Kallistratos MS, Tousoulis D, Makris T, Manolis AJ, Vardas P, Kallikazaros I.

Recent Pat Cardiovasc Drug Discov. 2013 Apr;8(1):35-41. Review.

PMID:
23565717
12.

Combination phentermine/topiramate for obesity treatment in primary care: a review.

Xiong GL, Gadde KM.

Postgrad Med. 2014 Mar;126(2):110-6. doi: 10.3810/pgm.2014.03.2746. Review.

PMID:
24685974
13.

Topiramate: a new potential pharmacological treatment for obesity.

Astrup A, Toubro S.

Obes Res. 2004 Dec;12 Suppl:167S-73S. Review.

PMID:
15687413
14.

Phentermine and topiramate for the management of obesity: a review.

Cosentino G, Conrad AO, Uwaifo GI.

Drug Des Devel Ther. 2011 Apr 5;7:267-78. doi: 10.2147/DDDT.S31443. Print 2013. Review.

15.

Antiobesity pharmacotherapy: new drugs and emerging targets.

Kim GW, Lin JE, Blomain ES, Waldman SA.

Clin Pharmacol Ther. 2014 Jan;95(1):53-66. doi: 10.1038/clpt.2013.204. Epub 2013 Oct 8. Review.

16.

Overview of new antiobesity drugs.

Hainer V.

Expert Opin Pharmacother. 2014 Oct;15(14):1975-8. doi: 10.1517/14656566.2014.946904. Epub 2014 Aug 6. Review.

PMID:
25100293
17.

[Cutting-edge of medicine; the prospects of novel anti-obesity drugs].

Ueno H, Nakazato M.

Nihon Naika Gakkai Zasshi. 2014 Mar 10;103(3):753-9. Review. Japanese. No abstract available.

PMID:
24796150
18.

The use of pharmacologic agents in the treatment of the obese patient.

Apovian CM.

J Am Osteopath Assoc. 1999 Oct;99(10 Su Pt 2):S2-7. Review.

PMID:
10624371
19.

Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.

Kramer CK, Leitão CB, Pinto LC, Canani LH, Azevedo MJ, Gross JL.

Obes Rev. 2011 May;12(5):e338-47. doi: 10.1111/j.1467-789X.2010.00846.x. Epub 2011 Mar 28. Review.

PMID:
21438989
20.

Combination therapy for obesity and metabolic disease.

Gadde KM, Allison DB.

Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):353-8. doi: 10.1097/MED.0b013e3283304f90. Review.

PMID:
19625958
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk